
Minimal impact on Indian pharma companies supplying medicines to US: Analysts
New Delhi, July 22 — Analysts on Wednesday said that there would be minimal impact on Indian pharma companies supplying medicines to US market, as US President Donald Trump has announced plans to impose tariffs on generic drugs from 2028.Multiple Indian companies have subsidiaries in the US and…




















